Human TNF-α
Synonyms: TNFSF2

TNF-α stands for tumor necrosis factor α, also termed TNFSF2 (TNF ligand superfamily member 2). Human TNF-α is a recombinant protein optimized for use in cell culture, differentiation studies, and functional assays.

Select a quality grade:
Select a size:
Other sizes

Related products for Human TNF-α

Specifications for Human TNF-α
Overview

TNF-α stands for tumor necrosis factor α, also termed TNFSF2 (TNF ligand superfamily member 2). Human TNF-α is a recombinant protein optimized for use in cell culture, differentiation studies, and functional assays.

Applications

TNF-α can be used for a variety of applications, including:

  • Induction of Mo-DC maturation.
  • Cytotoxicity and cell proliferation assays.
  • Assessment of apoptosis and viral protection.
  • Investigation of TNF-α–induced signaling pathways.
Alternative names

TNFSF2

Detailed product information

Biological activity

Determination method
Inhibition of L-929 cells (NIBSC 88/786)
Research grade
≥ 2×107 IU/mg
Premium grade
≥ 4×107 IU/mg (Typical activity 6×107 IU/mg)
We measure the biological activity of each batch of MACS Premium-Grade Cytokines and state the results in the Certificate of Analysis (CoA). Based on the lot-specific activity, exact doses of active cytokine can be applied to cell culture experiments. This allows for reproducible cell culture conditions without the need for time-consuming lot-to-lot testing.
Background information

Tumor necrosis factor α (TNF-α) is a proinflammatory cytokine mainly produced by activated monocytes and macrophages in response to infection, injury, and tumor burden. TNF-α production has also been reported for a variety of other cell types involved in inflammatory responses, including T cells, NK cells, and neutrophils as well as a number of non-immune cells, such as keratinocytes and astrocytes. TNF-α has a broad spectrum of biological activities. In addition to its central role in inflammation, TNF-α is noted for its cytotoxic and tumoricidal abilities either by necrosis or induction of apoptosis. Further functions include antiviral activity, growth modulation, and induction of cellular differentiation. Despite its various beneficial actions, TNF-α also plays a detrimental role in, for example, septic shock syndrome, tissue injury, inflammation, cachexia, and diabetes.

Quality description

Research-grade cytokines are suitable for a wide variety of cell culture applications. They are sterile-filtered prior to lyophilization. Generally, endotoxin levels are <0.1 ng/μg (<1 EU/μg), and purities are >95%. The biological activity is tested in appropriate bioassays.

Premium-grade cytokines offer the convenience of high and well-defined biological activities and allow exact unit dosing for demanding applications. The biological activity is determined after lyophilization and reconstitution, and normalized to WHO/NIBSC standards whenever available. In general, endotoxin levels are <0.01 ng/μg (<0.1 EU/μg), and purities are >97%. Lot-specific activities are stated in the Certificate of Analysis (www. miltenyibiotec.com/certificates).

Product data and images for Human TNF-α
Figure 1

Human TNF-α activity assay. The biological activity of Human TNF-α, premium grade was determined by inhibition assay using L-929 cells.

Figure 2

SDS-PAGE of Human TNF-alpha, premium grade under reducing (R) and non reducing (NR) conditions.

Figure 3

Mass spectrometry analysis (ESI-MS) of Human TNF-α, premium grade. The peak corresponds to the calculated molecular mass of 17353 Da.

Resources for Human TNF-α
Documents and Protocols
Certificates

To access a Certificate of Analysis (CoA) follow the link below and enter the specific lot of your product.

Get certificate

Should you wish to request additional documentation, such as a Safety Data Sheet (SDS) in other languages than English or Swedish, an SDS-replacement document, or a Certificate of Origin (CoO), please direct your inquiry to your local technical support team.

Contact technical support

Citations for Human TNF-α
Publications
  1. Clement, M. et al. (2016) Targeted suppression of autoreactive CD8 + T-cell activation using blocking anti-CD8 antibodies. Sci Rep 6: 35332
  2. Baarsch, M. J. et al. (1991) Detection of tumor necrosis factor alpha from porcine alveolar macrophages using an L929 fibroblast bioassay. J. Immunol. Methods 140: 15-22
  3. Boink, M. A. et al. (2017) Saliva-Derived Host Defense Peptides Histatin1 and LL-37 Increase Secretion of Antimicrobial Skin and Oral Mucosa Chemokine CCL20 in an IL-1 α-Independent Manner. J Immunol Res 2017: 3078194
  4. Barbara, J. A. et al. (1996) Tumour necrosis factor-alpha (TNF-alpha): the good, the bad and potentially very effective. Immunol. Cell Biol. 74: 434-443
  5. Bacher, P. et al. (2014) Antigen-specific expansion of human regulatory T cells as a major tolerance mechanism against mucosal fungi. Mucosal Immunol 7 (4): 916-928
  6. Ferroni, L. et al. (2020) Fluorescent Light Energy (FLE) Acts on Mitochondrial Physiology Improving Wound Healing. J Clin Med 9 (2): 559
  7. Voskamp, A. et al. (2013) MHC class II expression in human basophils: induction and lack of functional significance. PLoS One 8 (12): e81777
  8. Schweikert, E. M. et al. (2012) PON3 is upregulated in cancer tissues and protects against mitochondrial superoxide-mediated cell death. Cell Death Differ. 19 (9): 1549-1560
  9. Mayordomo, A. C. et al. (2018) IL-12/23p40 overproduction by dendritic cells leads to an increased Th1 and Th17 polarization in a model of Yersinia enterocolitica-induced reactive arthritis in TNFRp55-/- mice. PLoS One 13 (3): e0193573
  10. Islam, S. A. et al. (2013) Identification of human CCR8 as a CCL18 receptor. J. Exp. Med. 210 (10): 1889-1898
  11. Meurer, T. et al. (2018) Dissecting Genetic Control of HLA-DPB1 Expression and Its Relation to Structural Mismatch Models in Hematopoietic Stem Cell Transplantation. Front Immunol 9: 2236
  12. Kronenberg, D. et al. (2012) Circulating preproinsulin signal peptide-specific CD8 T cells restricted by the susceptibility molecule HLA-A24 are expanded at onset of type 1 diabetes and kill β-cells. Diabetes 61 (7): 1752-1759
  13. Garufi, A. et al. (2012) Targeting COX-2/PGE(2) pathway in HIPK2 knockdown cancer cells: impact on dendritic cell maturation. PLoS One 7 (11): e48342
  14. Black, R. A. et al. (1997) A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells. Nature 385: 729-733
  15. Paravati, R. et al. (2020) Differential regulation of osteopontin and CD44 correlates with infertility status in PCOS patients. J. Mol. Med. 98 (12): 1713-1725
  16. Schipper, H. S. et al. (2010) A multiplex immunoassay for human adipokine profiling. Clin. Chem. 56 (8): 1320-1328
  17. Nicoli, F. et al. (2021) Use of a Novel Peptide Welding Technology Platform for the Development of B- and T-Cell Epitope-Based Vaccines. Vaccines (Basel) 9 (5): 526
  18. Zhou, R. et al. (2020) Acute SARS-CoV-2 Infection Impairs Dendritic Cell and T Cell Responses. Immunity 53 (4): 864-877
  19. Cantoni, C. et al. (2021) Stromal-like Wilms tumor cells induce human Natural Killer cell degranulation and display immunomodulatory properties towards NK cells. Oncoimmunology 10 (1): 1879530
  20. Yeung, M. C. et al. (1996) An essential role for the interferon-inducible, double-stranded RNA-activated protein kinase PKR in the tumor necrosis factor-induced apoptosis in U937 cells. Proc. Natl. Acad. Sci. U.S.A. 93: 12451-12455
  21. Simo, R. et al. (2012) Potential role of tumor necrosis factor-α in downregulating sex hormone-binding globulin. Diabetes 61 (2): 372-382

You have previously chosen International as your location.
What do you want to do?